CD28 and neoplasm: These cells continue to express CD28, suggesting retained activation potential under certain conditions; however, their immune function is impaired by PD-1 expression, resulting in a loss of cytotoxicity and proliferation capacity (12–14) and rendering them less effective at eliminating tumor cells.